Contact Us
Global Nodular Prurigo Market Report 2025

Nodular Prurigo Global Market Report 2025 - By Type (Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo), By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants), By Patient Demographics (Adults, Children, Elderly), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Nodular Prurigo Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Nodular Prurigo Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

What Is Covered Under Nodular Prurigo Market?

Nodular prurigo, also known as prurigo nodularis, is a chronic skin condition marked by intensely itchy, firm nodules that commonly appear on the arms, legs, and torso. Nodular prurigo is a chronic skin condition of unclear cause involving immune, nerve, and inflammatory factors where persistent itching leads to excessive scratching, worsening the condition and causing scarring, and typically requires long-term dermatological management.

The main types of nodular prurigo are chronic nodular prurigo, acute nodular prurigo, and subacute nodular prurigo. Chronic nodular prurigo refers to a long-lasting form of prurigo characterized by the development of intensely itchy, firm nodules or bumps on the skin. These are used for various treatment types, including topical treatments, systemic treatments, Phototherapy, and immunosuppressants. The various patient demographics include adults, children, and the elderly and are used by various end users such as hospitals, homecare, specialty clinics, and others.

Nodular Prurigo Market Size and growth rate 2025 to 2029: Graph

What Is The Nodular Prurigo Market Size 2025 And Growth Rate?

The nodular prurigo market size has grown strongly in recent years. It will grow from $1.17 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising dermatology consultations, increased awareness among dermatologists, unmet medical need, academic research focus and improvements in diagnostic techniques.

What Is The Nodular Prurigo Market Growth Forecast?

The nodular prurigo market size is expected to see strong growth in the next few years. It will grow to $1.6 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the approval of targeted therapies, increased r&d funding for rare dermatologic conditions, stronger patient advocacy and awareness campaigns, health insurance and reimbursement expansion and companion diagnostics and biomarker development. Major trends in the forecast period include AI-driven diagnostics, gene editing, nanotechnology in drug delivery, biologics innovation, and wearable monitoring devices.

How Is The Nodular Prurigo Market Segmented?

The nodular prurigo market covered in this report is segmented –

1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo

2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants

3) By Patient Demographics: Adults, Children, Elderly

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo

2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers

3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants

What Is Driving The Nodular Prurigo Market? Increasing Demand For Targeted Therapies Fueling The Growth Of The Market Due To Their Precision And Improved Patient Outcomes

The increasing demand for targeted therapies is expected to propel the growth of the nodular prurigo market going forward. Targeted therapies refer to the medical treatments that specifically target and interfere with molecular pathways involved in the growth and spread of diseases. The rising demand for targeted therapies can be due to their ability to provide more precise treatments with fewer side effects, improving patient outcomes and offering alternatives to traditional, less specific therapies. Nodular prurigo helps drive the development of targeted therapies by presenting a clear unmet medical need involving specific immune pathways such as IL-4, IL-13, and IL-31, which enables the use of biologics that precisely block these inflammatory signals for more effective treatment. For instance, in October 2023, according to NHS England, a UK-based government agency, in England, 11 million hormone replacement therapy (HRT) items were prescribed, up 47% from 2021–22, with around 2.3 million patients receiving prescriptions, marking a 29% year-on-year increase. Therefore, the increasing demand for targeted therapies is driving growth in the nodular prurigo market.

Who Are The Major Players In The Global Nodular Prurigo Market?

Major companies operating in the nodular prurigo market are Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Galderma S.A., Galderma Laboratories L.P. , Incyte Corporation, Kyowa Kirin Co Ltd., LEO Pharma A/S, Maruho Co Ltd., Kiniksa Pharmaceuticals Ltd., Keymed Biosciences Co Ltd., Trevi Therapeutics Inc., Fierce Pharma, Menlo Therapeutics Inc., VYNE Therapeutics Inc., Celldex Therapeutics Inc.

What Are The Key Trends Of The Global Nodular Prurigo Market? Regulatory Approvals Driving Innovation In The Market

Major companies operating in the nodular prurigo market are focusing on getting regulatory approvals to expand market reach and improve patient outcomes. Regulatory approvals refer to the formal authorization granted by governmental or regulatory bodies for a drug, medical device, or treatment to be marketed and used by the public. For instance, in September 2022, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, received FDA approval for Dupixent (dupilumab), the first and only treatment specifically indicated for prurigo nodularis in adults. This approval was based on data from two pivotal Phase 3 trials (PRIME and PRIME2), which demonstrated that Dupixent significantly reduced itch and skin lesions compared to placebo. Dupixent became the only medicine in the U.S. with an approved indication for treating prurigo nodularis, addressing a substantial unmet medical need for approximately 75,000 adults affected by the condition in the U.S.

What Are Latest Mergers And Acquisitions In The Nodular Prurigo Market? Incyte Partnered With China Medical System Holdings To Expand Povorcitinib Development And Commercialization In Asia

In April 2024, Incyte Corporation, a US-based pharmaceutical company, partnered with China Medical System Holdings Limited to advance treatments for various autoimmune and inflammatory dermatologic conditions, including non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, asthma, and chronic spontaneous urticaria. China Medical System Holdings Limited is a Hong Kong-based pharmaceutical company that is involved in nodular prurigo treatment.

What Is The Regional Outlook For The Global Nodular Prurigo Market?

North America was the largest region in the nodular prurigo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nodular prurigo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nodular prurigo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nodular Prurigo Market?

The nodular prurigo market consists of revenues earned by entities by providing services such as diagnosis and clinical evaluation, prescription of topical treatments, phototherapy, biologic therapies, and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The nodular prurigo market also includes sales of products including oral antidepressants, JAK inhibitors, and topical calcineurin inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nodular Prurigo Industry?

The nodular prurigo market research report is one of a series of new reports from The Business Research Company that provides nodular prurigo market statistics, including nodular prurigo industry global market size, regional shares, competitors with a nodular prurigo market share, nodular prurigo market segments, market trends and opportunities, and any further data you may need to thrive in the nodular prurigo industry. This nodular prurigo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nodular Prurigo Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $1.25 billion
Revenue Forecast In 2034 $1.6 billion
Growth Rate CAGR of 6.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The nodular prurigo market covered in this report is segmented –
1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo
2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants
3) By Patient Demographics: Adults, Children, Elderly
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments:
1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo
2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers
3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Galderma S.A., Galderma Laboratories L.P. , Incyte Corporation, Kyowa Kirin Co Ltd., LEO Pharma A/S, Maruho Co Ltd., Kiniksa Pharmaceuticals Ltd., Keymed Biosciences Co Ltd., Trevi Therapeutics Inc., Fierce Pharma, Menlo Therapeutics Inc., VYNE Therapeutics Inc., Celldex Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Nodular Prurigo Market Characteristics

    3. Nodular Prurigo Market Trends And Strategies

    4. Nodular Prurigo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Nodular Prurigo Growth Analysis And Strategic Analysis Framework

    5.1. Global Nodular Prurigo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Nodular Prurigo Market Growth Rate Analysis

    5.4. Global Nodular Prurigo Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Nodular Prurigo Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Nodular Prurigo Total Addressable Market (TAM)

    6. Nodular Prurigo Market Segmentation

    6.1. Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Chronic Nodular Prurigo

    Acute Nodular Prurigo

    Subacute Nodular Prurigo

    6.2. Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Immunosuppressants

    6.3. Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Adults

    Children

    Elderly

    6.4. Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End-Users

    6.5. Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Idiopathic Chronic Nodular Prurigo

    Secondary To Dermatologic Conditions

    Neuropathic Causes

    Systemic Disease-Associated

    Psychogenic Prurigo

    6.6. Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Insect Bite-Induced

    Allergic Reactions

    Drug-Induced Prurigo

    Infectious Triggers

    6.7. Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Healing Phase Of Chronic Prurigo

    Post-Inflammatory Prurigo

    Transient Dermatoses

    Reaction To Environmental Irritants

    7. Nodular Prurigo Market Regional And Country Analysis

    7.1. Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Nodular Prurigo Market

    8.1. Asia-Pacific Nodular Prurigo Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Nodular Prurigo Market

    9.1. China Nodular Prurigo Market Overview

    9.2. China Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Nodular Prurigo Market

    10.1. India Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Nodular Prurigo Market

    11.1. Japan Nodular Prurigo Market Overview

    11.2. Japan Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Nodular Prurigo Market

    12.1. Australia Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Nodular Prurigo Market

    13.1. Indonesia Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Nodular Prurigo Market

    14.1. South Korea Nodular Prurigo Market Overview

    14.2. South Korea Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Nodular Prurigo Market

    15.1. Western Europe Nodular Prurigo Market Overview

    15.2. Western Europe Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Nodular Prurigo Market

    16.1. UK Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Nodular Prurigo Market

    17.1. Germany Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Nodular Prurigo Market

    18.1. France Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Nodular Prurigo Market

    19.1. Italy Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Nodular Prurigo Market

    20.1. Spain Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Nodular Prurigo Market

    21.1. Eastern Europe Nodular Prurigo Market Overview

    21.2. Eastern Europe Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Nodular Prurigo Market

    22.1. Russia Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Nodular Prurigo Market

    23.1. North America Nodular Prurigo Market Overview

    23.2. North America Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Nodular Prurigo Market

    24.1. USA Nodular Prurigo Market Overview

    24.2. USA Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Nodular Prurigo Market

    25.1. Canada Nodular Prurigo Market Overview

    25.2. Canada Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Nodular Prurigo Market

    26.1. South America Nodular Prurigo Market Overview

    26.2. South America Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Nodular Prurigo Market

    27.1. Brazil Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Nodular Prurigo Market

    28.1. Middle East Nodular Prurigo Market Overview

    28.2. Middle East Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Nodular Prurigo Market

    29.1. Africa Nodular Prurigo Market Overview

    29.2. Africa Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Nodular Prurigo Market Competitive Landscape And Company Profiles

    30.1. Nodular Prurigo Market Competitive Landscape

    30.2. Nodular Prurigo Market Company Profiles

    30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Nodular Prurigo Market Other Major And Innovative Companies

    31.1. Astellas Pharma Inc.

    31.2. Sun Pharmaceutical Industries Limited

    31.3. Galderma S.A.

    31.4. Galderma Laboratories L.P. 

    31.5. Incyte Corporation

    31.6. Kyowa Kirin Co Ltd.

    31.7. LEO Pharma A/S

    31.8. Maruho Co Ltd.

    31.9. Kiniksa Pharmaceuticals Ltd.

    31.10. Keymed Biosciences Co Ltd.

    31.11. Trevi Therapeutics Inc.

    31.12. Fierce Pharma

    31.13. Menlo Therapeutics Inc.

    31.14. VYNE Therapeutics Inc.

    31.15. Celldex Therapeutics Inc.

    32. Global Nodular Prurigo Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Nodular Prurigo Market

    34. Recent Developments In The Nodular Prurigo Market

    35. Nodular Prurigo Market High Potential Countries, Segments and Strategies

    35.1 Nodular Prurigo Market In 2029 - Countries Offering Most New Opportunities

    35.2 Nodular Prurigo Market In 2029 - Segments Offering Most New Opportunities

    35.3 Nodular Prurigo Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Merck & Co Inc. Financial Performance
  • Table 79: Sanofi S.A. Financial Performance
  • Table 80: GlaxoSmithKline plc Financial Performance
  • Table 81: Amgen Inc. Financial Performance
  • Table 82: Regeneron Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Merck & Co Inc. Financial Performance
  • Figure 79: Sanofi S.A. Financial Performance
  • Figure 80: GlaxoSmithKline plc Financial Performance
  • Figure 81: Amgen Inc. Financial Performance
  • Figure 82: Regeneron Pharmaceuticals Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Nodular Prurigo market?

Nodular prurigo, also known as prurigo nodularis, is a chronic skin condition marked by intensely itchy, firm nodules that commonly appear on the arms, legs, and torso. Nodular prurigo is a chronic skin condition of unclear cause involving immune, nerve, and inflammatory factors where persistent itching leads to excessive scratching, worsening the condition and causing scarring, and typically requires long-term dermatological management. For further insights on the Nodular Prurigo market, request a sample here

How will the Nodular Prurigo market drivers and restraints affect the market dynamics? What forces will shape the Nodular Prurigo industry going forward?

The Nodular Prurigo market major growth driver - Increasing Demand For Targeted Therapies Fueling The Growth Of The Market Due To Their Precision And Improved Patient Outcomes. For further insights on the Nodular Prurigo market, request a sample here

What is the forecast market size or the forecast market value of the Nodular Prurigo market?

The Nodular Prurigo market size has grown strongly in recent years. The nodular prurigo market size has grown strongly in recent years. It will grow from $1.17 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising dermatology consultations, increased awareness among dermatologists, unmet medical need, academic research focus and improvements in diagnostic techniques. The nodular prurigo market size is expected to see strong growth in the next few years. It will grow to $1.6 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the approval of targeted therapies, increased r&d funding for rare dermatologic conditions, stronger patient advocacy and awareness campaigns, health insurance and reimbursement expansion and companion diagnostics and biomarker development. Major trends in the forecast period include AI-driven diagnostics, gene editing, nanotechnology in drug delivery, biologics innovation, and wearable monitoring devices. For further insights on the Nodular Prurigo market, request a sample here

How is the Nodular Prurigo market segmented?

The nodular prurigo market covered in this report is segmented –
1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo
2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants
3) By Patient Demographics: Adults, Children, Elderly
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo
2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers
3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants For further insights on the Nodular Prurigo market,
request a sample here

Which region has the largest share of the Nodular Prurigo market? What are the other regions covered in the report?

North America was the largest region in the nodular prurigo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nodular prurigo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Nodular Prurigo market, request a sample here.

Who are the major players in the Nodular Prurigo market?

Major companies operating in the nodular prurigo market are Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Galderma S.A., Galderma Laboratories L.P. , Incyte Corporation, Kyowa Kirin Co Ltd., LEO Pharma A/S, Maruho Co Ltd., Kiniksa Pharmaceuticals Ltd., Keymed Biosciences Co Ltd., Trevi Therapeutics Inc., Fierce Pharma, Menlo Therapeutics Inc., VYNE Therapeutics Inc., Celldex Therapeutics Inc. . For further insights on the Nodular Prurigo market, request a sample here.

What are the key trends in the Nodular Prurigo market?

Major trends in the Nodular Prurigo market include Regulatory Approvals Driving Innovation In The Market. For further insights on the Nodular Prurigo market, request a sample here.

What are the major opportunities in the Nodular Prurigo market? What are the strategies for the Nodular Prurigo market?

For detailed insights on the major opportunities and strategies in the Nodular Prurigo market, request a sample here.

How does the Nodular Prurigo market relate to the overall economy and other similar markets?

For detailed insights on Nodular Prurigo's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Nodular Prurigo industry?

For detailed insights on the mergers and acquisitions in the Nodular Prurigo industry, request a sample here.

What are the key dynamics influencing the Nodular Prurigo market growth? SWOT analysis of the Nodular Prurigo market.

For detailed insights on the key dynamics influencing the Nodular Prurigo market growth and SWOT analysis of the Nodular Prurigo industry, request a sample here.